Product Description
Dual Growth-Hormone Signaling Research Blend
Tesamorelin and Ipamorelin are combined in a 17 mg dual-compound formulation containing Tesamorelin 11mg and Ipamorelin 6mg. This blend is studied in laboratory models involving growth-hormone pulsatility, visceral-fat metabolism, body recomposition, lean-mass preservation, recovery, and sleep-related pathways.
Tesamorelin is a synthetic growth-hormone-releasing hormone analog that is studied for its interaction with GHRH receptors on the pituitary gland and its ability to stimulate endogenous growth-hormone production. Research has examined tesamorelin in relation to visceral abdominal-fat reduction, metabolic signaling, body composition, and preservation of lean tissue.
Ipamorelin is a selective ghrelin mimetic and growth hormone secretagogue studied for its activity at the GHSR-1a receptor. It is commonly investigated for promoting a targeted growth-hormone pulse with comparatively limited stimulation of cortisol and prolactin signaling.
By engaging two separate receptor pathways, the formulation provides a controlled framework for studying a coordinated endocrine signal. Tesamorelin-associated pituitary GHRH signaling is paired with Ipamorelin-associated ghrelin-receptor activation to examine whether combined pathway engagement produces a more stable or amplified pulsatile growth-hormone response than either compound alone.
Key Research Areas
🧬
Dual-receptor endocrine signaling through simultaneous investigation of pituitary GHRH receptors and ghrelin-associated GHSR-1a pathways
⚡
Pulsatile growth-hormone output in laboratory models examining coordinated endogenous GH secretion and combined secretagogue activity
🎯
Visceral abdominal-fat metabolism in research involving deep adipose tissue surrounding internal organs and related metabolic pathways
📊
Body recomposition and lean-mass preservation in controlled models examining fat-loss phases, muscle retention, and tissue composition
🛠️
Recovery and tissue-repair pathways in research involving muscular recovery, joint-related soreness, physical stress, and restorative physiology
🌙
Sleep-cycle and restorative signaling in models examining sleep depth, recovery-associated hormonal patterns, and overnight physiological repair
🔬
Selective endocrine-response research with attention to Ipamorelin-associated growth-hormone signaling and comparatively limited cortisol or prolactin activation
This 17 mg presentation supports controlled dual-compound endocrine research designs, making it suitable for investigations across GHRH receptor signaling, GHSR-1a activation, pulsatile growth-hormone release, visceral-fat metabolism, body recomposition, lean-mass preservation, recovery, tissue repair, sleep-cycle signaling, and cortisol or prolactin selectivity.
Intended Use
📦 Format: Lyophilized powder (Tesamorelin 11mg + Ipamorelin 6mg = 17mg total)
⚠️ Use: For laboratory research use only. Not for human or veterinary use.
Why Researchers Choose This Formulation
🔗
Complementary receptor-pathway coverage supports investigation of Tesamorelin-associated GHRH signaling and Ipamorelin-associated GHSR-1a activation within one controlled research model.
⚡
Coordinated pulsatile GH research provides a framework for studying whether dual-pathway activation produces a stronger, more stable, or more consistent endocrine signal than single-compound protocols.
📊
Broad body-composition research relevance supports studies involving visceral abdominal fat, fat-loss phases, lean-mass preservation, metabolic signaling, and tissue composition.
🛠️
Integrated recovery and sleep research utility offers a focused framework for examining muscular recovery, joint-related soreness, restorative sleep patterns, and repair-associated physiology.
Product Notes
✅ Research category: Growth-hormone signaling, endocrine response, body composition, and recovery
✅ Study context: Laboratory and non-clinical research models
✅ Blend composition: Tesamorelin 11mg and Ipamorelin 6mg
✅ Tesamorelin focus: GHRH-receptor signaling, pituitary growth-hormone production, visceral abdominal-fat metabolism, and body composition
✅ Ipamorelin focus: GHSR-1a activation, selective ghrelin-mimetic activity, pulsatile growth-hormone release, and cortisol or prolactin selectivity
✅ Combined research focus: Dual-pathway endocrine signaling, visceral-fat reduction, lean-mass preservation, recovery, sleep, muscle soreness, and joint-related research
